LFS and OS by disease type. (A) LFS by type of leukemia, defined as the time from transplantation to relapse or death in the patients who achieved engraftment. (B) LFS by HLA match. (C) LFS by ATG exposure. (D) OS by type of leukemia, defined as the time from transplantation to death from any cause. (E) OS by HLA match. (F) OS by ATG exposure.